These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 6539524)
1. Orchiectomy and chemotherapy with estramustine, cis-platinum, cyclophosphamide, and 5-fluorouracil in newly diagnosed prostate cancer with bone metastases. Eisenkraft S; Huben RP; Pontes JE Urology; 1984 Jun; 23(6 Suppl):51-3. PubMed ID: 6539524 [No Abstract] [Full Text] [Related]
12. Use of estramustine phosphate in prostate cancer by the National Prostatic Cancer Project and by roswell park memorial institute. Murphy GP; Slack NH; Mittelman A Urology; 1984 Jun; 23(6 Suppl):54-63. PubMed ID: 6375081 [No Abstract] [Full Text] [Related]
13. Chemotherapy for hormone-refractory prostate cancer. Shelley M; Harrison C; Coles B; Staffurth J; Wilt TJ; Mason MD Cochrane Database Syst Rev; 2006 Oct; (4):CD005247. PubMed ID: 17054249 [TBL] [Abstract][Full Text] [Related]
14. Long-term control or possible cure? Treatment of stage D2 prostate cancer under chemotherapy using cisplatin and estramustine phosphate followed by maximal androgen blockade. Urakami S; Shiina H; Sumura M; Honda S; Wake K; Hiraoka T; Inoue S; Ishikawa N; Igawa M Int Urol Nephrol; 2008; 40(2):365-8. PubMed ID: 18092143 [TBL] [Abstract][Full Text] [Related]
15. Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer. Smith DC; Esper P; Strawderman M; Redman B; Pienta KJ J Clin Oncol; 1999 Jun; 17(6):1664-71. PubMed ID: 10561202 [TBL] [Abstract][Full Text] [Related]
16. [A case of castration-refractory prostate cancer showing marked decrease of serum PSA level after zoledronic acid treatment with estramustine phosphate and prednisolone]. Hirayama Y; Ito Y; Kanamaru T; Sonoda T; Aoyama M; Nakamura N; Kawamura M Gan To Kagaku Ryoho; 2011 Mar; 38(3):485-7. PubMed ID: 21403461 [TBL] [Abstract][Full Text] [Related]
17. Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide. National Prostatic Cancer Project randomized trial. Murphy GP; Priore RL; Scardino PT Urology; 1988 Jul; 32(1):33-40. PubMed ID: 3291371 [TBL] [Abstract][Full Text] [Related]